Are the factors affecting adverse pregnancy outcomes different in obese gestational diabetes pregnant women receiving diet or insulin treatment?

Basit Öğe Kaydı
dc.authoridBaşak Gümüş Güler / 0000-0002-0182-6774
dc.authorscopusidBaşak Gümüş Güler / 57193546825
dc.authorwosidBaşak Gümüş Güler / JHA-5039-2023
dc.contributor.authorÖzler, Sibel
dc.contributor.authorÖztaş, Efser
dc.contributor.authorGümüş Güler, Başak
dc.contributor.authorAlcı, M.
dc.contributor.authorÇağlar, Ali Turhan
dc.contributor.authorDanışman, Nuri
dc.date.accessioned2020-08-30T20:06:31Z
dc.date.available2020-08-30T20:06:31Z
dc.date.issued2019
dc.departmentİstinye Üniversitesi, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümüen_US
dc.description.abstractContext. We aimed to examine the factors affecting adverse gestational outcome in gestational diabetes (GDM) patients, who were grouped as obese and normal-weight, having only-diet, or insulin treatments. Subjects and Methods. The study included 373 patients, treated with diet or insulin. These patients were sub-grouped as obese and non-obese, and examined retrospectively. The variables affecting adverse gestational outcome in obese GDM patients having dietary and/or insulin treatments were detected with multiple regression analysis. Results. The weight gained during pregnancy in the GDM group having insulin treatment was more than the one in only-diet treated GDM group (p=0.004). Pre-pregnancy body mass index, the weight gained during pregnancy, hemoglobin A1C levels in the second and third trimesters, caesarian rates were higher in the insulin-treated obese patients than in the other groups (p<0.001). The odds ratio for fasting blood glucose level in insulin-treated obese GDM group was 1.081 (95% CI = 1.004 - 1.163) (p=0.039); and it was 0.982 (95% CI = 0.924 - 1.002) (p=0.048) for the weight gained during pregnancy, in only-diet treated obese GDM patients. Conclusion. The control of weight gained during pregnancy, and of fasting blood glucose levels in obese patients having GDM, is important to decrease adverse gestational outcome.en_US
dc.identifier.citationOzler, S., Oztas, E., Guler, B. G., Alci, M., Caglar, A. T., & Danisman, N. (2019). ARE THE FACTORS AFFECTING ADVERSE PREGNANCY OUTCOMES DIFFERENT IN OBESE GESTATIONAL DIABETES PREGNANT WOMEN RECEIVING DIET OR INSULIN TREATMENT? ACTA ENDOCRINOLOGICA-BUCHAREST, 15(4), 472–481. https://doi.org/10.4183/aeb.2019.472en_US
dc.identifier.doi10.4183/aeb.2019.472en_US
dc.identifier.endpage481en_US
dc.identifier.issn1841-0987en_US
dc.identifier.issn1843-066Xen_US
dc.identifier.issue4en_US
dc.identifier.pmid32377245en_US
dc.identifier.scopus2-s2.0-85089626510en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage472en_US
dc.identifier.urihttps://doi.org/10.4183/aeb.2019.472
dc.identifier.urihttps://hdl.handle.net/20.500.12713/540
dc.identifier.volume15en_US
dc.identifier.wosWOS:000540348500010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorGümüş Güler, Başaken_US
dc.language.isoenen_US
dc.publisherEditura Acad Romaneen_US
dc.relation.ispartofActa Endocrinologica-Bucharesten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectObese Gestational Diabetesen_US
dc.subjectAdverse Pregnancy Outcomesen_US
dc.subjectWeight Gain During Pregnancyen_US
dc.subjectDiet Therapyen_US
dc.subjectInsulin Therapyen_US
dc.titleAre the factors affecting adverse pregnancy outcomes different in obese gestational diabetes pregnant women receiving diet or insulin treatment?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
32.pdf
Boyut:
360.77 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Hemşirelik Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu